Randox at ECCMID 2019 - 1.77

Location : Amsterdam, Netherlands
  Date : 13th-16th April 2019

Dedicated to Improving Health Worldwide

Randox Laboratories will be attending the 29th European Congress of Clinical Microbiology and Infections from the 13th-16th April 2019.Our innovative diagnostic solutions have been developed with consolidation and economy in mind, providing cost savings whilst using pioneering technology.

Diagnostics is our passion. We are dedicated to developing solutions that not only meet your needs, but that are of the highest quality, the most reliable and the most cost-effective. We look forward to meeting you in Amsterdam at the RAI Amsterdam. 

Randox Discovery

Powered by Biochip Array Technology

The Randox Discovery is an exciting and disruptive molecular diagnostic testing technology. The fully automated multiplex analyser consolidates the normal workload of multiple laboratory rooms into one compact benchtop platform.

The system utilises ready to use cartridge based prefabricated reagents. 1 to 16 patient samples can be analysed simultaneously utilising Randox Biochip Array Technology. The machine is comprised of three interconnected modules with the first module performing sample extraction and purification moving onto PCR followed hybridisation to the biochip and first results reported after 3 hours.

Bosch Vivalytic

 The all in one solution for Molecular Diagnostics

A game-changing partnership between Randox Laboratories and Bosch is changing the accessibility to molecular diagnostics with the launch of a revolutionary product – the innovative platform Vivalytic. Vivalytic provides the broadest range of test options ever seen for its size. Using Randox-patented Biochip Array Technology, it is the easiest-to-use and most-comprehensive multiplex PCR platform on the market.The device also supports single-plex and low-plex testing, simplifying the processes for otherwise-complex laboratory test procedures. Depending on the test application, results will be delivered from 30 minutes.

What can we offer?

As an international company, with 25 offices and distribution channels in 145 countries, Randox products and services are utilized in many settings. Our comprehensive portfolio includes:

Clinical Chemistry Analyzers

The RX series of clinical chemistry analyzers combines robust hardware and intuitive software ensuring unrivalled precision and accuracy for results you can trust

Reagents

Committed to advancing biochemistry testing for laboratories. We offer a range of high quality reagents that cover routine and novel markers with applications for use on a wide range of clinical chemistry analyzers.

Quality Controls

Combining true third party controls, online QC data management and the world’s largest global proficiency testing scheme to ensure accurate diagnosis.

Evidence Series

The Evidence series of immunoassay analyzers have been developed using patented Biochip Array Technology. Developed by Randox Laboratories in 2002, highly innovative Biochip Array Technology (BAT) instantly changed the landscape of diagnostic testing forever.

Randox Biosciences

Randox Biosciences is part of Randox Laboratories and brings together four specialist divisions advancing scientific discovery, drug development, and diagnostics.